scispace - formally typeset
A

Audrius V. Plioplys

Researcher at Mercy Hospital and Medical Center

Publications -  28
Citations -  1780

Audrius V. Plioplys is an academic researcher from Mercy Hospital and Medical Center. The author has contributed to research in topics: Chronic fatigue syndrome & Autism. The author has an hindex of 17, co-authored 28 publications receiving 1711 citations. Previous affiliations of Audrius V. Plioplys include University of Illinois at Chicago & Mercy Medical Center (Baltimore, Maryland).

Papers
More filters
Journal ArticleDOI

A community-based study of chronic fatigue syndrome.

TL;DR: Earlier findings suggesting that CFS is a syndrome primarily affecting white, middle-class patients were not supported, and the highest levels of CFS were consistently found among women, minority groups, and persons with lower levels of education and occupational status.
Journal ArticleDOI

Lymphocyte function in autism and Rett syndrome.

TL;DR: 11 of 17 autistic patients had an abnormally increased percentage of DR+ but not IL-2 receptor+ lymphocytes suggesting 'incomplete' activation, a finding which is seen in autoimmune diseases.
Journal ArticleDOI

A screening instrument for chronic fatigue syndrome: Reliability and validity

TL;DR: While the instrument differentiates patients with CFS from those who are healthy, it is less likely to distinguish C FS from other autoimmune diseases (especially Lupus), so future community-based CFS prevalence studies should encompass both a screening instrument and second stage medical assessment.
Journal ArticleDOI

Autism: Electroencephalogram Abnormalities and Clinical Improvement With Valproic Acid

TL;DR: There is little evidence to suggest that seizure-free children with rare spikes or other paroxysmal EEG discharges will benefit from anticonvulsants, and in a recent review of autism, Rapin 5 wrote.
Journal ArticleDOI

Intravenous immunoglobulin treatment of children with autism.

TL;DR: Given a positive response rate of only 10% in this study, the use of intravenous immunoglobulin to treat autistic children should be undertaken only with great caution, and only under formal research protocols.